1. Quinn T., Ostrom M.A., Gittlemaneds Н. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2011-2015. Neurooncology. 2018;20(4):1-86. doi: 10.1093/neuonc/noy171.
2. ECIS. Estimates of cancer incidence and mortality in 2018. European commission. September 21, 2018. Available at: https://ecis.jrc.ec.europa.eu/explorer.php?$0-0$1-All$2-All$4-1,2$3-44$6-0,14$5-2008,2008$7-7$CEstByCountry$X0_8-3$X0_19-AE28E$X0_20-No$CEstRelative$X1_8-3$X1_9-AE28$X1_19-AE28E$CEstByCountryTable$X2_19-AE28E.
3. Quinn T., Ostrom M.A., Gittleman Н. eds. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012 Neurooncology. 2015;17(4):1-62. doi: 10.1093/neuonc/nov189.
4. Naskhletashvili D.R., Bekyashev A.Kh., Karakhan V.B., Aleshin V.A., Fu R.G., Belov D.M., Chmutin E.G.Role of temozolomide in the treatment of glioblastomas. Opukholi golovy I shei = Head and Neck Tumors (HNT).2011;(2):34-35. (in Russ.) Available at: https://elibrary.ru/item.asp?id = 16542739.
5. Kaprin A.D., Starinskiy V.V., Petrova G.V. (eds). Cancer statistics in Russia in 2017. Moscow: Gertsen P.A. Moscow Cancer Research Institute – filial of TSYB Medical Radiological Research Center of the Ministry of Health of Russia; 2018. (In Russ.) Available at: http://www.oncology.ru/service/statistics/malignant_tumors/2017.pdf.